New Horizon Health Limited

SEHK:6606 Voorraadrapport

Marktkapitalisatie: HK$6.3b

New Horizon Health Beheer

Beheer criteriumcontroles 3/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Yeqing Zhu

Algemeen directeur

CN¥48.8m

Totale compensatie

Percentage CEO-salaris8.3%
Dienstverband CEO6yrs
Eigendom CEO3.4%
Management gemiddelde ambtstermijn6yrs
Gemiddelde ambtstermijn bestuur3.3yrs

Recente managementupdates

Recent updates

New Horizon Health Limited (HKG:6606) Stocks Shoot Up 29% But Its P/S Still Looks Reasonable

Mar 04
New Horizon Health Limited (HKG:6606) Stocks Shoot Up 29% But Its P/S Still Looks Reasonable

Should You Investigate New Horizon Health Limited (HKG:6606) At HK$18.38?

Jan 30
Should You Investigate New Horizon Health Limited (HKG:6606) At HK$18.38?

Should You Think About Buying New Horizon Health Limited (HKG:6606) Now?

Sep 28
Should You Think About Buying New Horizon Health Limited (HKG:6606) Now?

New Horizon Health (HKG:6606) Is Posting Healthy Earnings, But It Is Not All Good News

Sep 28
New Horizon Health (HKG:6606) Is Posting Healthy Earnings, But It Is Not All Good News

Benign Growth For New Horizon Health Limited (HKG:6606) Underpins Stock's 26% Plummet

Aug 02
Benign Growth For New Horizon Health Limited (HKG:6606) Underpins Stock's 26% Plummet

New Forecasts: Here's What Analysts Think The Future Holds For New Horizon Health Limited (HKG:6606)

Jul 14
New Forecasts: Here's What Analysts Think The Future Holds For New Horizon Health Limited (HKG:6606)

News Flash: Analysts Just Made A Substantial Upgrade To Their New Horizon Health Limited (HKG:6606) Forecasts

Mar 19
News Flash: Analysts Just Made A Substantial Upgrade To Their New Horizon Health Limited (HKG:6606) Forecasts

Growth Investors: Industry Analysts Just Upgraded Their New Horizon Health Limited (HKG:6606) Revenue Forecasts By 26%

Jan 13
Growth Investors: Industry Analysts Just Upgraded Their New Horizon Health Limited (HKG:6606) Revenue Forecasts By 26%

News Flash: Analysts Just Made A Captivating Upgrade To Their New Horizon Health Limited (HKG:6606) Forecasts

Mar 23
News Flash: Analysts Just Made A Captivating Upgrade To Their New Horizon Health Limited (HKG:6606) Forecasts

Need To Know: Analysts Are Much More Bullish On New Horizon Health Limited (HKG:6606) Revenues

Jan 19
Need To Know: Analysts Are Much More Bullish On New Horizon Health Limited (HKG:6606) Revenues

Analyse CEO-vergoeding

Hoe is Yeqing Zhu's beloning veranderd ten opzichte van New Horizon Health's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2023n/an/a

CN¥112m

Mar 31 2023n/an/a

CN¥16m

Dec 31 2022CN¥49mCN¥4m

-CN¥79m

Sep 30 2022n/an/a

-CN¥169m

Jun 30 2022n/an/a

-CN¥259m

Mar 31 2022n/an/a

-CN¥2b

Dec 31 2021CN¥14mCN¥3m

-CN¥3b

Compensatie versus markt: De totale vergoeding ($USD 6.73M ) Yeqing } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Hong Kong markt ($USD 500.67K ).

Compensatie versus inkomsten: De vergoeding van Yeqing is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.


CEO

Yeqing Zhu (52 yo)

6yrs

Tenure

CN¥48,829,000

Compensatie

Mr. Yeqing Zhu serves as Executive Chairman at New Horizon Health Limited since June 20, 2022. He is the Chief Executive Officer of New Horizon Health Ltd. since June 7, 2018.Mr. Zhu is an Executive Direc...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Yeqing Zhu
CEO, Executive Chairman & Co-founder6yrsCN¥48.83m3.36%
HK$ 213.4m
Yiyou Chen
Executive Director & Chief Scientific Officer6yrsCN¥11.04m8.14%
HK$ 516.4m
Yu Gao
CFO & Joint Company Secretary4yrsgeen gegevensgeen gegevens
Ning Lu
Chief Technology Officer8.6yrsgeen gegevensgeen gegevens
Ming-Wai Mok
Joint Company Secretary3.4yrsgeen gegevensgeen gegevens

6.0yrs

Gemiddelde duur

52yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 6606 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 6 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Yeqing Zhu
CEO, Executive Chairman & Co-founder6yrsCN¥48.83m3.36%
HK$ 213.4m
Yiyou Chen
Executive Director & Chief Scientific Officer6yrsCN¥11.04m8.14%
HK$ 516.4m
Weng Sin Ng
Independent Non-Executive Directorless than a yeargeen gegevensgeen gegevens
Danke Yu
Independent Non-executive Director3.3yrsCN¥266.00kgeen gegevens
Naxin Yao
Non-executive Director5.9yrsgeen gegevens5.14%
HK$ 325.9m
Kwok Tung Li
Independent Non-executive Director3.3yrsCN¥266.00kgeen gegevens
Ngai Kee Lau
Independent Non-Executive Directorless than a yeargeen gegevensgeen gegevens
Hong Wu
Independent Non-executive Director3.3yrsCN¥266.00kgeen gegevens

3.3yrs

Gemiddelde duur

54yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 6606 wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.3 jaar).